| Financial Year |
March 31 2023 |
| Monetary Funds |
39,140,379.16 |
| Held-for-trading Financial Assets |
286,568.16 |
| Notes Receivable |
400,000.00 |
| Accounts Receivable |
103,210,724.26 |
| Advances to Suppliers |
6,646,345.24 |
| Other Receivables |
196,339,738.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
145,737,139.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,399.69 |
| Total Current Assets |
521,449,224.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
198,971,437.46 |
| Under-construction Projects |
599,042.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,553,083.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
624,312.70 |
| Sub-Total of Non-Current Assets |
217,747,876.74 |
| Total Assets |
739,197,101.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,172,071.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,288,941.14 |
| Taxes Payable |
5,669,526.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,602,385.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
635,576.49 |
| Sub-Total of Current Liabilities |
51,787,824.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,798,310.23 |
| Total Liabilities |
54,586,134.77 |
| Paid-In Capital(Or Share Stock) |
153,287,400.00 |
| Capital Surplus |
839,264,378.05 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-307,940,811.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
684,610,966.72 |
| Owner's Equity（Stockholder's Equity） |
684,610,966.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
739,197,101.49 |
